Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 16, 2022

Total Value: $279M (100.0% shares, 0.0% debt)

Holdings (46)

ASND ASCENDIS PHARMA A/S 9.2%
Value $25.56M Shares 190,000 Est. Cost $131.68 Unrealized
APLS APELLIS PHARMACEUTICALS INC 5.5%
Value $15.37M Shares 325,000 Est. Cost $49.72 Unrealized -20.8%
COGT COGENT BIOSCIENCES INC 5.2%
Value $14.59M Shares 1,700,000 Est. Cost $10.34 Unrealized -15.9%
CLDX CELLDEX THERAPEUTICS INC NEW 4.8%
Value $13.52M Shares 350,000 Est. Cost $28.96 Unrealized +50.5%
RAPT THERAPEUTICS INC 4.6%
Value $12.86M Shares 350,000 Est. Cost $33.20 Unrealized
MERUS N V 4.0%
Value $11.13M Shares 350,000 Est. Cost $29.50 Unrealized
IVERIC BIO INC 3.7%
Value $10.45M Shares 625,000 Est. Cost $7.44 Unrealized
VRDN VIRIDIAN THERAPEUTICS INC 3.5%
Value $9.885M Shares 500,000 Est. Cost $18.53 Unrealized +0.5%
IOVA IOVANCE BIOTHERAPEUTICS INC 3.4%
Value $9.545M Shares 500,000 Est. Cost $24.32 Unrealized -9.5%
RCKT ROCKET PHARMACEUTICALS INC 3.3%
Value $9.278M Shares 425,000 Est. Cost $29.94 Unrealized -8.9%
ARVN ARVINAS INC 3.2%
Value $9.035M Shares 110,000 Est. Cost $28.07 Unrealized +189.9%
SRPT SAREPTA THERAPEUTICS INC 3.2%
Value $9.005M Shares 100,000 Est. Cost $85.49 Unrealized 0.0%
BELLUS HEALTH INC NEW 2.6%
Value $7.173M Shares 891,000 Est. Cost $6.35 Unrealized
ZNTL ZENTALIS PHARMACEUTICALS INC 2.4%
Value $6.725M Shares 80,000 Est. Cost $61.38 Unrealized +26.1%
SNDX SYNDAX PHARMACEUTICALS INC 2.4%
Value $6.567M Shares 300,000 Est. Cost $18.21 Unrealized +1.5%
PCVX VAXCYTE INC 2.1%
Value $5.948M Shares 250,000 Est. Cost $21.70 Unrealized +7.2%
FOLD AMICUS THERAPEUTICS INC 2.1%
Value $5.775M Shares 500,000 Est. Cost $12.96 Unrealized -14.0%
SIERRA ONCOLOGY INC 1.9%
Value $5.435M Shares 250,000 Est. Cost $17.17 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 1.8%
Value $5.087M Shares 30,000 Est. Cost $185.86 Unrealized 0.0%
VERONA PHARMA PLC 1.8%
Value $5.04M Shares 750,000 Est. Cost $6.53 Unrealized
WHWK AADI BIOSCIENCE INC 1.7%
Value $4.83M Shares 200,000 Est. Cost $25.11 Unrealized 0.0%
ACRS ACLARIS THERAPEUTICS INC 1.7%
Value $4.726M Shares 325,000 Est. Cost $6.81 Unrealized +122.5%
CMPS COMPASS PATHWAYS PLC 1.7%
Value $4.641M Shares 210,000 Est. Cost $25.80 Unrealized
RLMD RELMADA THERAPEUTICS INC 1.6%
Value $4.506M Shares 200,000 Est. Cost $26.77 Unrealized -16.9%
MIRATI THERAPEUTICS INC 1.6%
Value $4.401M Shares 30,000 Est. Cost $98.34 Unrealized
LEAP THERAPEUTICS INC 1.6%
Value $4.374M Shares 1,350,000 Est. Cost $4.01 Unrealized
KEZAR LIFE SCIENCES INC 1.5%
Value $4.18M Shares 250,000 Est. Cost $16.72 Unrealized
SATSUMA PHARMACEUTICALS INC 1.5%
Value $4.069M Shares 904,225 Est. Cost $10.24 Unrealized
VISTAGEN THERAPEUTICS INC 1.4%
Value $3.9M Shares 2,000,000 Est. Cost $2.02 Unrealized
TARS TARSUS PHARMACEUTICALS INC 1.4%
Value $3.825M Shares 170,000 Est. Cost $31.23 Unrealized -16.8%
BELLUS HEALTH INC NEW 1.3%
Value $3.623M Shares 450,000 Est. Cost $6.35 Unrealized
CRNX CRINETICS PHARMACEUTICALS IN 1.2%
Value $3.362M Shares 118,344 Est. Cost $17.57 Unrealized +40.3%
PYXS PYXIS ONCOLOGY INC 1.2%
Value $3.236M Shares 295,000 Est. Cost $11.45 Unrealized 0.0%
9 METERS BIOPHARMA INC 1.1%
Value $3.181M Shares 3,250,000 Est. Cost $1.25 Unrealized
KURA KURA ONCOLOGY INC 1.1%
Value $3.15M Shares 225,000 Est. Cost $28.09 Unrealized -42.3%
XENE XENON PHARMACEUTICALS INC 1.1%
Value $3.124M Shares 100,000 Est. Cost $13.60 Unrealized +119.7%
CTI BIOPHARMA CORP 1.1%
Value $2.976M Shares 1,200,000 Est. Cost $2.84 Unrealized
DSGN DESIGN THERAPEUTICS INC 1.0%
Value $2.89M Shares 135,000 Est. Cost $17.17 Unrealized 0.0%
LRMR LARIMAR THERAPEUTICS INC 0.9%
Value $2.428M Shares 225,000 Est. Cost $11.59 Unrealized -4.1%
GHRS GH RESEARCH PLC 0.8%
Value $2.333M Shares 100,000 Est. Cost $20.35 Unrealized +7.9%
GLOBAL BLOOD THERAPEUTICS IN 0.6%
Value $1.756M Shares 60,000 Est. Cost $29.27 Unrealized
IMUX IMMUNIC INC 0.6%
Value $1.579M Shares 165,000 Est. Cost $16.38 Unrealized -45.0%
REATA PHARMACEUTICALS INC 0.5%
Value $1.45M Shares 55,000 Est. Cost $26.36 Unrealized
ALDX ALDEYRA THERAPEUTICS INC 0.4%
Value $1.2M Shares 300,000 Est. Cost $4.92 Unrealized +54.9%
PARDES BIOSCIENCES INC 0.3%
Value $819K Shares 50,000 Est. Cost $16.38 Unrealized
CABA CABALETTA BIO INC 0.2%
Value $512K Shares 135,000 Est. Cost $9.60 Unrealized +11.2%